PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 12, 2025Nanoscale2 citationsOpen Access

iRGD-engineered exosomes mediate siMYC delivery for effective tumor suppression in triple-negative breast cancer

View Full Paper
HLHui LiWYWeiguang YuanJLJialin Liu

Key Points

  • To investigate the role of iRGD-engineered exosomes in delivering siMYC for tumor suppression in triple-negative breast cancer.
  • Utilization of iRGD-engineered exosomes for targeted delivery of siMYC
  • Evaluation of tumor suppression efficacy in vitro and in vivo models of triple-negative breast cancer
  • Demonstrated effective delivery of siMYC via iRGD-engineered exosomes
  • Achieved significant tumor suppression in TNBC models

Abstract

Triple-negative breast cancer (TNBC) is an aggressive cancer with a poor prognosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/6941aae10f5af7fd17df58fchttps://doi.org/10.1039/d5nr04841a
Ask AI
Helpful
Bookmark
Share
View Full Paper